News
As the AI wave plays out, creating more value over the next decade, could we see global venture investment double or more ...
9d
Pharmaceutical Technology on MSNVC firm Vivo Capital outlays $740m for biotech investmentSet against a backdrop of barren biotech investment, Vivo Capital has secured $740m to back preclinical and clinical-stage ...
California investment firm Vivo Capital has secured $740 million in commitments to be aimed at preclinical- and ...
Dublin, May 12, 2025 (GLOBE NEWSWIRE) -- The "Venture Capital Investment Trends In Pharma - Q1 2025" report has been added to ResearchAndMarkets.com's offering. This report analyzes the venture ...
The flow of investment capital into the ... their stages of development and growth, and venture capital is the lifeblood that feeds the cycle. But Tulsa is an interesting case study when it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results